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Stiff-person syndrome (SPS) is a disabling disorder of the central nervous system that is characterized by
episodic rigidity and spasticity. We report the case of a woman who had SPS with cerebellar manifes-
tations (SPS-Cer) and asymmetric deformed feet. SPS-Cer is a rare phenotype that has a poor prognosis
for improvement of cerebellar function, even after adequate treatment.
Copyright  2013, Taiwan Society of Geriatric Emergency & Critical Care Medicine. Published by Elsevier
Taiwan LLC. All rights reserved.1. Introduction
Stiff person syndrome is a rare and under-diagnosed disease. In
this report, we represent a case of stiff person syndrome with un-
usual clinical manifestation of feet deformities and cerebellar
ataxia. It is a crucial to list stiff person syndrome in the differential
diagnosis upon encountering a patient with episodic falls.2. Case report
A 67-year-old woman with a 7-year history of type 2 diabetes
mellitus had episodic lower limb and axial stiffness within the past
10 years. Muscle contractions were provoked by anxiety and un-
expected loud voices. Her symptoms were relieved when she
calmed down and rested. Muscle spasms caused frequent falls that
resulted in broken teeth and a broken left arm. The cramping did
not occur during sleep. No prodromal event preceded the episodes.
None of her family members had similar symptoms.nd foreseeable future, all af-
ganization or entity with a
ject matter or materials dis-
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iwan Society of Geriatric EmergenThe patient also visited a psychiatric clinic and was diagnosed as
having anxiety. Anxiolytics were prescribed, but the unexpected
stiffness continued to occur periodically over the 10 years. Her
usual social life was adversely affected because of her fear of falling
down.
Upon admission, there was no evidence that her pyramidal
tracts, extrapyramidal tracts, or mental abilities were affected. She
did have awide-based gait (Video 1). In addition, she had deformed
feet (Fig. 1) without muscle atrophy. The foot deformities were
asymmetric with a spontaneous up-pointing left big toe.
Supplementary data related to this article can be found at http://
dx.doi.org/10.1016/j.ijge.2013.03.004.
Brain magnetic resonance imaging (MRI) and nerve conduction
studies revealed no speciﬁc ﬁndings. Electromyography of the pa-
tient’s bilateral lower extremities showed continuous muscle ac-
tivity, especially in the tibialis anterior muscles bilaterally.
Blood tests showed abnormally elevated titers of antimicrosomal
(1:1600) and antithyroglobulin (1:1600) antibodies, and the patient’s
serum antiglutamic acid decarboxylase (anti-GAD) level was 7513
U/mL. Thyroid function tests, antinuclear antibody, insulin anti-
bodies, thyroid-stimulating hormone receptor antibodies, and tumor
markers including carcinoembryonic antigen (CEA), carbohydrate
antigen 19-9 (CA19-9), CA-125, and alpha-fetoprotein were within
normal limits. Stiff-person syndrome (SPS) was suspected (Box), and
diazepam 1 mg three times a day was prescribed. A dramatic
response in terms of reduction in muscle stiffness was reported by
the patient: after beginning diazepam therapy, she was able walk
outdoors without unexpected muscle cramps. However, her wide-
based gait (Video 2) and foot deformities remained (Fig. 2).cy & Critical Care Medicine. Published by Elsevier Taiwan LLC. All rights reserved.
Fig. 1. Left foot deformity before diazepam.
Fig. 2. Deformity of the feet after diazepam.
Box
The Dalakas criteria for the diagnosis of typical stiff-person
syndrome5.
 Stiffness in the axial muscles, prominently in the
abdominal and thoracolumbar paraspinal muscle
leading to a fixed deformity (hyperlordosis)
 Superimposed painful spasms precipitated by unex-
pected noises, emotional stress, tactile stimuli
 Confirmation of the continuous motor unit activity in
agonist and antagonist muscles by electromyography
 Absence of neurological or cognitive impairments that
could explain the stiffness
 Positive serology for GAD 65 (or amphiphysin) auto-
antibodies, assessed by immunocytochemistry, west-
ern blot or radioimmunoassay
 Response to diazepam
This box is reproduced with permission from copyright
owner.
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The clinical symptoms, electrophysiological examination ﬁnd-
ings, high serum anti-GAD titer, and good response to diazepam
supported the diagnosis of SPS1.3. Discussion
A case of a patient who had SPS with cerebellar symptoms (SPS-
Cer) and asymmetric deformed feet is reported.
Cerebellar involvement was suggested by the wide-based gait of
our patient, which did not improve even after diazepam usage. SPS
accompanied by cerebellar manifestations is rare. Goran et al
studied ﬁve patients with SPS-Cer. Their patients also had normal
brain MRI ﬁndings. The patients with SPS-Cer showed an
improvement in stiffness after treatment with GABAergic medica-
tions, but the cerebellar signs remained. They considered SPS-Cer
to be a more severe and complex clinical subset2. Our patient
showed similar results: a good response in terms of reducing un-
expected muscle stiffness but a poor response in terms of relieving
cerebellar ataxia.
Mario-Ubaldo et al analyzed rats that had received intra-
cerebellar and paraspinal administration of anti-GAD IgG. The re-
sults indicated that SPS and cerebellar ataxia were the direct
consequence of antibody-mediated neuronal dysfunction3. Mario-
Ubaldo et al also administered puriﬁed anti-GAD antibodies, ob-
tained from neurology patients, and monoclonal GAD65 antibodies
with distinct epitope speciﬁcities (b78 and b96.11) to rat cerebel-lums in vivo. Their results suggested that, in vivo, neurologic im-
pairments caused by anti-GAD antibodies could vary according to
epitope speciﬁcities. These results could explain the different
neurologic syndromes observed in patients with anti-GAD
antibodies4.
Although both stiffness and spasms usually predominate in axial
muscles in a symmetric manner, asymmetric involvement of the
feet or even hands was present in only 30% of cases1. Our patient
showed more severe impairment of her left foot than of her right.
This rare clinical phenotype suggested more complicated disease
and a difﬁcult recovery of the cerebellar manifestations.References
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